Search

everythinglearnresearchcommunity

for

Search:↓

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

People with androgenetic alopecia have a higher risk of heart disease.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

The new rodent model successfully mimics non-lean human PCOS symptoms.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Finasteride helps induce ovulation in nonresponder PCOS women.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.